E. Eisenhauer
AIDS Clinical Trials Group(US)
Publications by Year
Research Areas
Cancer Treatment and Pharmacology, Ovarian cancer diagnosis and treatment, Lung Cancer Research Studies, Lung Cancer Treatments and Mutations, Cancer, Lipids, and Metabolism
Most-Cited Works
- → New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)(2008)28,935 cited
- → RECIST revisited: A review of validation studies on tumour assessment(2006)421 cited
- → Evaluation of lymph nodes with RECIST 1.1(2008)291 cited
- → Speeding up the Evaluation of New Agents in Cancer(2008)150 cited
- → Gemcitabine is an active new agent in previously untreated extensive small cell lung cancer (SCLC)(1994)147 cited
- → Lessons learned from independent central review(2008)114 cited
- → Successful re-treatment with taxol after major hypersensitivity reactions.(1993)113 cited
- → Phase II study of the progesterone antagonist mifepristone in patients with untreated metastatic breast carcinoma: a National Cancer Institute of Canada Clinical Trials Group study.(1996)97 cited
- → A phase II study of perifosine (D-21226) in patients with previously untreated metastatic or locally advanced soft tissue sarcoma: A National Cancer Institute of Canada Clinical Trials Group trial(2006)83 cited
- → Carboplatin versus cisplatin(1993)76 cited